Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Blood Glucose Regulators > Tirzepatide for Sale > TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial
TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial buy - large image1
TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial buy - image1
TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial buy - image2
TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial buy - image3
TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial buy - image4

TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial

TDS 2103 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Industrial Grade

Content:

99%

Port:

SHENGZHEN

Brand:

KSD

Packaging:

30mg/cardboard

Price valid (until):

2026-08-31

Company Type:
Trader
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
14 days
Qualification:
Main Products:

Semaglutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


    Contact Us  


    • Name:Chloe
    • WeChat and WhatApps:+852 6732 2979
    • Emails:3524465053@qq.com

      Product Detail:

    • TR30 stands for Tirzepatide 30mg/vial. CAS:2023788-19-2. Dual GLP‑1/GIP receptor agonist peptide, white lyophilized powder. Raw material for metabolic related lab research. 

    • As a dual GLP‑1/GIP receptor agonist peptide, it is widely used in preclinical pharmacological research focusing on metabolic pathways and blood glucose regulation.

    Items Specifications
    Product Name Tirzepatide
    Purity 99%
    Appearance White powder
    Storage Dry and Cool Place
    Grade Medical grade


    Product Features:

    1.Standard specification: 30mg Tirzepatide lyophilized powder per sterile vial, 10 vials per plastic pack, accurate dosing for lab tests.


    2.Superior stability: White lyophilized peptide powder effectively slows degradation, easy to reconstitute for preclinical research.


    .3.Dual-receptor agonist: Activates GLP-1 and GIP receptors, ideal raw material for metabolic & glucose pathway research.


    4.High purity level: Manufactured under strict QC standards; COA certificate available, low impurities to reduce experimental interference.


    5.Independent sealed vial packaging: Orange cap sterile glass vials, well isolated from moisture and air for convenient storage.


    Product features and images:


    Shop TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial-Detailed Image 1 Shop TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial-Detailed Image 2




    How to order


    Shop TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial-Detailed Image 3


    WHY Choose Us


    1.High quality products with competitive pricing.


    2.Free samples available for your evaluation and testing.


    3.Fast, reliable delivery via reputable shipping lines.


    4.Trial orders are welcome for quality verification after sample approval.


    5.Proactive updates and full transparency at every stage of your order.


    6.Custom packaging solutions tailored to meet your specific requirements.


      Company Profile  


    About KSD

    Jinan Kang Shengda Technology Co., Ltd. | Professional Peptide Manufacturer | Driving Innovation in Life Science Research

    As a professional high-tech enterprise rooted in Jinan, Jinan Kang Shengda Technology has 8 years of experience in the peptide raw material industry. The company integrates peptide R&D, standardized production, quality testing, and customized support services, focusing on the supply of high-purity synthetic peptides, bioactive peptides, and natural plant extract raw materials.

    With a mature laboratory R&D platform, strict comprehensive quality management, and standardized purification production workshops, we implement rigorous HPLC purity testing, impurity control, and stability testing for all peptide products. Complete testing documentation ensures consistent and stable product quality for our global customers.

    We provide reliable peptide raw materials and one-stop customized solutions to research laboratories, biomedical companies, biotechnology institutions, and biochemical research institutions worldwide. Backed by solid technical reserves and stable mass production capabilities, we can provide robust quality assurance for your research projects and bulk procurement needs. Shop TR30 Tirzepatide 30mg/vial Lyophilized Peptide Vial-Detailed Image 4


      FQA 


    1. Q: What are your production cycle and delivery time?
    A: For regular in-stock peptide products, the production cycle is 3 to 7 working days. We ship entirely by air, and the entire transportation cycle from the date of delivery is 10 to 14 working days. Ample stock ensures a long-term, stable, and uninterrupted supply.

    2. Q: What are your main export markets?

    A: Our products are sold worldwide, including the United States, Canada, Australia, the Netherlands, New Zealand, Italy, France, Germany, Mexico, and many other countries and regions.

    3. Q: What customer service and after-sales support do you provide?
    A: We provide comprehensive customer support throughout the entire service process. If you encounter problems with product quality, air transport damage, shipping documents, or product usage guidelines, our team will respond quickly and provide practical solutions to fully protect your legal rights.

    4. Q: How is the quality of your products?

    A: Each batch of products undergoes rigorous quality inspection before delivery to ensure HPLC purity is higher than 99%. Complete inspection documents, such as product certificates and HPLC reports, will be provided for your reference.

    5. Q: Which logistics method do you use for shipping?

    A: We use professional air freight for all peptide shipments, combined with cold chain packaging, to maintain the activity and stability of the peptides during transportation.

    6. Q: What payment methods do you support for orders?

    A: We support Alipay,  Bitcoin, and USDT for your selection.


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide

    Location:

    Licheng District, Jinan City, Shandong Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

    Company Certificates
    • Jinan Kangshengda Technology Co., Ltd.Retatrutide coa Retatrutide coa
    Hello and welcome to learn about Kangshengda Biotechnology! We are a specialized enterprise dedicated to the R&D and production of peptide products. Leveraging high-quality peptide preparations, our core strength lies in supporting customers to achieve long-term weight management and all-round health regulation.
    Boasting extensive mature export experience, our products are sold to Europe, the United States and numerous other countries and regions worldwide. Supported by consistent, reliable product quality, efficient on-time delivery and a comprehensive professional after-sales service system, we have built long-term, solid strategic partnerships with overseas distributors.
    We are committed to delivering one-stop customized premium peptide solutions for all clients, and seek long-term development and win-win cooperation alongside domestic and global partners!
    KSD
    ">KSD
  • Inquiry History
    2103 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.